Dosage form: injection
Drug class:MTOR inhibitors
Medically reviewed by Drugs.com. Last updated on Apr 21, 2022.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Temsirolimus Injection
Temsirolimus Injection is indicated for the treatment of advanced renal cell carcinoma.
Temsirolimus Injection Dosage and Administration
Advanced Renal Cell Carcinoma
The recommended dose of Temsirolimus Injection for advanced renal cell carcinoma is 25 mg administered as an intravenous infusion over a 30-60 minute period once a week.
Treatment should continue until disease progression or unacceptable toxicity occurs.
